The Pak4 Protein Kinase in Breast Cancer

Overview

Journal ISRN Oncol

Specialty Oncology

Date 2013 Jan 18

PMID 23326684

Citations 16

Authors

Audrey Minden

Affiliations

Soon will be listed here.

Abstract

Paks4, along with Paks5, and 6 are members of the group B family of p21-activated kinases (Paks). The Paks play multiple different roles in controlling cell morphology, cell growth, proliferation, and signaling. Pak4 has essential roles in embryonic development (Qu et al., 2003), but in adults high levels of Pak4 are frequently associated with cancer. Pak4 has been implicated in several types of cancer (Wells and Jones, 2010; Eswaran et al., 2009; Liu et al., 2008; and Liu et al., 2010) and it is strongly linked to breast cancer (Liu et al., 2008; Liu et al. 2010; Yu et al., 2009; Rafn et al., 2012; and So et al., 2012). Breast tumors and breast cancer cell lines frequently have high levels of Pak4 (Liu et al., 2008), and overexpression of Pak4 in mammary epithelial cells leads to tumorigenesis in mice (Liu et al., 2010). This paper summarizes the current work on the role of Pak4 in breast cancer.

Citing Articles

Nuplazid suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting PAK4.

Wei Y, Wu W, Jiang Y, Zhou H, Yu Y, Zhao L Br J Cancer. 2021; 126(7):1037-1046.

PMID: 34912075 PMC: 8980085. DOI: 10.1038/s41416-021-01651-z.

hsa-miR-199a-3p Inhibits Motility, Invasiveness, and Contractility of Ovarian Endometriotic Stromal Cells.

Zhu R, Nasu K, Hijiya N, Yoshihashi M, Hirakawa T, Aoyagi Y Reprod Sci. 2021; 28(12):3498-3507.

PMID: 33987822 DOI: 10.1007/s43032-021-00604-4.

Recognition of physiological phosphorylation sites by p21-activated kinase 4.

Chetty A, Sexton J, Ha B, Turk B, Boggon T J Struct Biol. 2020; 211(3):107553.

PMID: 32585314 PMC: 7395882. DOI: 10.1016/j.jsb.2020.107553.

KPT-9274, an Inhibitor of PAK4 and NAMPT, Leads to Downregulation of mTORC2 in Triple Negative Breast Cancer Cells.

Cordover E, Wei J, Patel C, Shan N, Gionco J, Sargsyan D Chem Res Toxicol. 2019; 33(2):482-491.

PMID: 31876149 PMC: 9316853. DOI: 10.1021/acs.chemrestox.9b00376.

Release of transcriptional repression via ErbB2-induced, SUMO-directed phosphorylation of myeloid zinc finger-1 serine 27 activates lysosome redistribution and invasion.

Brix D, Tvingsholm S, Bredahl Hansen M, Clemmensen K, Ohman T, Siino V Oncogene. 2019; 38(17):3170-3184.

PMID: 30622337 PMC: 6525100. DOI: 10.1038/s41388-018-0653-x.

References

Gringel A, Walz D, Rosenberger G, Minden A, Kutsche K, Kopp P . PAK4 and alphaPIX determine podosome size and number in macrophages through localized actin regulation. J Cell Physiol. 2006; 209(2):568-79. DOI: 10.1002/jcp.20777. View

Murray B, Guo C, Piraino J, Westwick J, Zhang C, Lamerdin J . Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth. Proc Natl Acad Sci U S A. 2010; 107(20):9446-51. PMC: 2889050. DOI: 10.1073/pnas.0911863107. View

Wells C, Whale A, Parsons M, Masters J, Jones G . PAK4: a pluripotent kinase that regulates prostate cancer cell adhesion. J Cell Sci. 2010; 123(Pt 10):1663-73. PMC: 2864712. DOI: 10.1242/jcs.055707. View

Wallace S, Durgan J, Jin D, Hall A . Cdc42 regulates apical junction formation in human bronchial epithelial cells through PAK4 and Par6B. Mol Biol Cell. 2010; 21(17):2996-3006. PMC: 2929993. DOI: 10.1091/mbc.E10-05-0429. View

Debnath J, Mills K, Collins N, Reginato M, Muthuswamy S, Brugge J . The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell. 2002; 111(1):29-40. DOI: 10.1016/s0092-8674(02)01001-2. View

Molli P, Li D, Murray B, Rayala S, Kumar R . PAK signaling in oncogenesis. Oncogene. 2009; 28(28):2545-55. PMC: 2731678. DOI: 10.1038/onc.2009.119. View

Gutierrez C, Schiff R . HER2: biology, detection, and clinical implications. Arch Pathol Lab Med. 2011; 135(1):55-62. PMC: 3242418. DOI: 10.5858/2010-0454-RAR.1. View

Wells C, Jones G . The emerging importance of group II PAKs. Biochem J. 2010; 425(3):465-73. DOI: 10.1042/BJ20091173. View

Qu J, Li X, Novitch B, Zheng Y, Kohn M, Xie J . PAK4 kinase is essential for embryonic viability and for proper neuronal development. Mol Cell Biol. 2003; 23(20):7122-33. PMC: 230313. DOI: 10.1128/MCB.23.20.7122-7133.2003. View

10.

Arias-Romero L, Villamar-Cruz O, Pacheco A, Kosoff R, Huang M, Muthuswamy S . A Rac-Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells. Oncogene. 2010; 29(43):5839-49. PMC: 2965784. DOI: 10.1038/onc.2010.318. View

11.

Yu W, Kanaan Y, Bae Y, Baed Y, Gabrielson E . Chromosomal changes in aggressive breast cancers with basal-like features. Cancer Genet Cytogenet. 2009; 193(1):29-37. PMC: 2768045. DOI: 10.1016/j.cancergencyto.2009.03.017. View

12.

Basolo F, Elliott J, Tait L, Chen X, Maloney T, Russo I . Transformation of human breast epithelial cells by c-Ha-ras oncogene. Mol Carcinog. 1991; 4(1):25-35. DOI: 10.1002/mc.2940040106. View

13.

Gnesutta N, Qu J, Minden A . The serine/threonine kinase PAK4 prevents caspase activation and protects cells from apoptosis. J Biol Chem. 2001; 276(17):14414-9. DOI: 10.1074/jbc.M011046200. View

14.

Liu Y, Chen N, Cui X, Zheng X, Deng L, Price S . The protein kinase Pak4 disrupts mammary acinar architecture and promotes mammary tumorigenesis. Oncogene. 2010; 29(44):5883-94. PMC: 2974003. DOI: 10.1038/onc.2010.329. View

15.

Wang R, Zhang H, Balasenthil S, Medina D, Kumar R . PAK1 hyperactivation is sufficient for mammary gland tumor formation. Oncogene. 2005; 25(20):2931-6. DOI: 10.1038/sj.onc.1209309. View

16.

Zhao Z, Manser E . Do PAKs make good drug targets?. F1000 Biol Rep. 2010; 2:70. PMC: 2989626. DOI: 10.3410/B2-70. View

17.

Liu Y, Xiao H, Tian Y, Nekrasova T, Hao X, Lee H . The pak4 protein kinase plays a key role in cell survival and tumorigenesis in athymic mice. Mol Cancer Res. 2008; 6(7):1215-24. PMC: 2822623. DOI: 10.1158/1541-7786.MCR-08-0087. View

18.

Eswaran J, Soundararajan M, Kumar R, Knapp S . UnPAKing the class differences among p21-activated kinases. Trends Biochem Sci. 2008; 33(8):394-403. DOI: 10.1016/j.tibs.2008.06.002. View

19.

Eswaran J, Soundararajan M, Knapp S . Targeting group II PAKs in cancer and metastasis. Cancer Metastasis Rev. 2009; 28(1-2):209-17. DOI: 10.1007/s10555-008-9181-4. View

20.

Zhang H, Siu M, Yeung M, Jiang L, Mak V, Ngan H . Overexpressed PAK4 promotes proliferation, migration and invasion of choriocarcinoma. Carcinogenesis. 2011; 32(5):765-71. DOI: 10.1093/carcin/bgr033. View